StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
141
This month
2
This year
12
Publishing Date
2024 - 01 - 04
2
2023 - 11 - 15
2
2023 - 06 - 27
2
2023 - 05 - 24
2
2023 - 01 - 26
2
2022 - 09 - 27
2
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 06 - 09
1
2022 - 06 - 07
2
2022 - 06 - 03
1
2022 - 06 - 02
1
2022 - 05 - 31
1
2022 - 05 - 11
1
2022 - 05 - 05
1
2022 - 04 - 28
1
2022 - 04 - 21
2
2022 - 04 - 13
1
2022 - 04 - 08
1
2022 - 04 - 06
1
2022 - 03 - 31
1
2022 - 03 - 29
2
2022 - 03 - 16
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 01 - 27
1
2022 - 01 - 11
1
2021 - 12 - 22
1
2021 - 12 - 21
1
2021 - 12 - 15
1
2021 - 12 - 08
1
2021 - 12 - 01
1
2021 - 11 - 30
1
2021 - 11 - 29
1
2021 - 11 - 23
1
2021 - 11 - 15
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 11 - 02
1
2021 - 11 - 01
1
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 10 - 11
3
2021 - 10 - 01
1
2021 - 09 - 27
1
2021 - 09 - 15
1
2021 - 09 - 09
1
2021 - 08 - 19
1
2021 - 08 - 17
1
2021 - 08 - 12
1
2021 - 08 - 09
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 22
1
2021 - 07 - 13
1
2021 - 07 - 09
1
Sector
Finance
1
Finance and insurance
1
Health technology
14
Manufacturing
9
N/a
141
Tags
Acquisition
2
Agreement
2
Alliances
7
Application
7
Approval
5
Biocanada
41
Biotech
2
Biotechnology
5
Business
4
Clearance
2
Clinical-trials-phase-i
3
Clinical-trials-phase-ii
11
Conference
23
Corporation
2
Cyb003
24
Cyb004
11
Day
2
Depression
2
Drug
8
Earnings
7
Europe
2
Events
27
Fda
8
Financial
4
Financial results
4
Flow
2
Global
3
Grant
9
Granted
3
Growth
5
Hospital
2
International
2
License
4
Major depressive disorder
7
Meeting
6
N/a
13
Neuropsychiatric
2
New drug
2
Offering
2
Order
4
Patent
11
People
3
Pharma
5
Phase 1
11
Phase 2
4
Positive
6
Pre-clinical
2
Preclinical
3
Presentation
3
Program
8
Psilocybin
7
Research
26
Results
13
Study
8
Therapeutics
9
Topline
4
Train
5
Treatment
15
Trial
20
Update
3
Entities
180 life sciences corp.
179
Abb ltd
439
Advantest corp
90
Alvotech lux holdings s.a.s.
92
Arrival
98
Atlas copco ab
117
Atlas lithium corp
311
Aura fat projects acquisition corp
257
Beigene, ltd.
119
Blue world acquisition corp
177
Bouygues sa
83
Brainsway ltd.
112
Byline bancorp, inc.
123
Bynordic acquisition corp
309
Canon inc
151
Cf acquisition corp. vii
333
Cybin inc
141
Daimler ag
79
Dmy technology group, inc. vi
110
Encore energy corp.
100
Esab corp
199
Fat projects acquisition corp
410
Hesai group
83
Honeywell international inc.
206
Ix acquisition corp.
129
Johnson & johnson
114
Kamada ltd.
86
Kenvue inc.
100
Kodiak gas services, inc.
270
Koninklijke philips n.v.
78
Lexaria bioscience corp
85
Lithium corp
396
Liveone inc
93
M3-brigade acquisition iii corp.
115
Mallinckrodt plc
132
Medies
294
Metal sky star acquisition corp
315
Mind medicine inc (sub voting)
118
Mobiv acquisition corp
214
Murphy canyon acquisition corp.
98
Nikola corporation
95
Nyxoah sa
80
Orange
164
Oxbridge acquisition corp.
93
Panasonic corp
651
Pegasus digital mobility acquisition corp.
191
Provention bio, inc.
113
Pyrophyte acquisition corp.
84
Quantum fintech acquisition corp
209
Rcf acquisition corp.
101
Relief therapeutics holding sa
109
Sanofi
196
Sealsq corp
159
Sofi technologies inc
90
Teva pharmaceutical industries ltd
123
Tkb critical technologies 1
234
Transalta corporation
80
Vision sensing acquisition corp.
534
Winvest acquisition corp.
77
Wisekey international holding ag
105
Symbols
ATAI
8
AXSM
1
BETRF
2
CMPS
6
CYBN
141
ENVB
4
GBNH
1
HTGC
1
JNJ
4
KTTA
1
MDBH
1
MNMD
3
SEEL
2
SILO
1
SNY
3
SNYNF
3
TNXP
2
Exchanges
Nasdaq
15
Nyse
141
Crawled Date
2023 - 11 - 15
2
2023 - 06 - 27
2
2023 - 05 - 24
2
2023 - 01 - 26
2
2022 - 09 - 27
2
2022 - 06 - 27
1
2022 - 06 - 22
1
2022 - 06 - 16
1
2022 - 06 - 09
1
2022 - 06 - 07
2
2022 - 06 - 03
1
2022 - 06 - 02
1
2022 - 05 - 31
1
2022 - 05 - 11
1
2022 - 05 - 05
1
2022 - 04 - 28
1
2022 - 04 - 21
2
2022 - 04 - 13
1
2022 - 04 - 08
1
2022 - 04 - 06
1
2022 - 03 - 31
1
2022 - 03 - 29
2
2022 - 03 - 16
1
2022 - 02 - 10
1
2022 - 02 - 09
1
2022 - 01 - 27
1
2022 - 01 - 11
1
2021 - 12 - 22
1
2021 - 12 - 21
1
2021 - 12 - 15
1
2021 - 12 - 08
1
2021 - 12 - 01
1
2021 - 11 - 30
1
2021 - 11 - 29
1
2021 - 11 - 23
1
2021 - 11 - 15
1
2021 - 11 - 11
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 11 - 04
1
2021 - 11 - 02
1
2021 - 11 - 01
1
2021 - 10 - 28
1
2021 - 10 - 26
1
2021 - 10 - 19
1
2021 - 10 - 12
1
2021 - 10 - 11
3
2021 - 10 - 01
1
2021 - 09 - 27
1
2021 - 09 - 15
1
2021 - 09 - 09
1
2021 - 08 - 19
1
2021 - 08 - 17
1
2021 - 08 - 12
1
2021 - 08 - 09
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 22
1
2021 - 07 - 13
1
2021 - 07 - 09
1
Crawled Time
00:00
1
07:00
1
08:00
1
09:00
1
11:00
2
12:00
19
12:15
3
12:20
12
12:30
5
13:00
49
13:20
5
13:30
10
14:00
10
14:20
2
15:00
1
15:20
1
15:30
3
16:00
3
17:00
1
18:00
3
19:00
1
21:00
2
22:00
3
23:00
2
Source
www.biospace.com
128
www.globenewswire.com
3
www.prnewswire.com
10
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
N::A
entities :
Cybin inc
save search
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
Published:
2024-04-18
(Crawled : 14:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-7.8%
|
O:
-2.0%
H:
0.0%
C:
0.0%
publication
research
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published:
2024-04-10
(Crawled : 13:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-18.21%
|
O:
-1.96%
H:
0.0%
C:
-4.65%
conference
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas
Published:
2024-03-18
(Crawled : 17:00)
- biospace.com/
MDBH
|
$9.1284
2.36%
1.4K
|
|
2.58%
|
O:
-1.69%
H:
7.09%
C:
5.26%
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-23.91%
|
O:
0.0%
H:
0.22%
C:
-2.17%
day
Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder
Published:
2024-03-15
(Crawled : 12:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-18.41%
|
O:
1.59%
H:
7.78%
C:
5.55%
cyb004
study
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
Published:
2024-03-14
(Crawled : 12:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-16.67%
|
O:
7.14%
H:
5.53%
C:
-4.67%
cyb003
fda
positive
meeting
program
design
Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order
Published:
2024-03-12
(Crawled : 11:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-12.28%
|
O:
-5.59%
H:
18.53%
C:
16.8%
meeting
order
therapeutics
agreement
Cybin Reports Third Quarter Financial Results and Recent Business Highlights
Published:
2024-02-14
(Crawled : 13:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-2.62%
|
O:
-1.31%
H:
0.0%
C:
-2.17%
business
financial
results
Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
Published:
2024-02-07
(Crawled : 13:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
6.09%
|
O:
1.42%
H:
0.0%
C:
-10.34%
japan
grant
program
Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
Published:
2024-01-26
(Crawled : 15:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-3.31%
|
O:
-0.61%
H:
2.83%
C:
2.83%
therapeutics
Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
Published:
2024-01-23
(Crawled : 13:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-7.89%
|
O:
0.0%
H:
2.37%
C:
0.34%
cyb004
fda
clearance
study
Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
Published:
2024-01-04
(Crawled : 00:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-8.85%
|
O:
0.65%
H:
3.49%
C:
3.49%
first
fibromyalgia
treatment
trial
therapeutics
Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs
Published:
2024-01-04
(Crawled : 13:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-8.85%
|
O:
0.65%
H:
3.49%
C:
3.49%
topline
results
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program
Published:
2023-12-06
(Crawled : 13:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-19.45%
|
O:
-2.65%
H:
2.36%
C:
1.65%
cyb003
patent
grant
program
psilocybin
Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results
Published:
2023-12-05
(Crawled : 15:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-21.75%
|
O:
-1.63%
H:
0.45%
C:
-1.25%
cyb003
topline
meeting
results
Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-26.93%
|
O:
2.3%
H:
0.0%
C:
-8.14%
cyb003
positive
topline
study
Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City
Published:
2023-11-20
(Crawled : 13:30)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-22.22%
|
O:
2.04%
H:
0.17%
C:
-1.68%
cyb003
review
depression
city
topline
study
Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting
Published:
2023-11-15
(Crawled : 14:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-23.91%
|
O:
0.22%
H:
1.74%
C:
-1.3%
presentation
meeting
Cybin Reports Second Quarter Financial Results and Recent Business Highlights
Published:
2023-11-15
(Crawled : 08:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-23.91%
|
O:
0.22%
H:
1.74%
C:
-1.3%
business
financial
results
Cybin Announces up to US$64 Million Offering of Units
Published:
2023-11-10
(Crawled : 14:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-30.75%
|
O:
-12.45%
H:
3.95%
C:
-3.28%
offering
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose
Published:
2023-10-31
(Crawled : 23:00)
- biospace.com/
CYBN
|
$0.355
-1.44%
3.5M
|
n/a
|
-42.27%
|
O:
11.35%
H:
9.32%
C:
-4.16%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
1.79%
|
O:
0.33%
H:
0.0%
C:
0.0%
AXSM
|
$71.23
-2.53%
-2.6%
580K
|
Health Technology
|
21.74%
|
O:
0.0%
H:
3.76%
C:
3.75%
cyb003
rapid
positive
depression
meeting
← Previous
1
2
3
4
5
6
7
8
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.